DIN 02417162 — CONSTELLA 145 MCG
CONSTELLA is a capsule of Linaclotide marketed by ABBVIE CORPORATION. The full Linaclotide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02417162
- Brand name
- CONSTELLA
- Active ingredient
- Linaclotide
- Strength
- 145 MCG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Guanylate cyclase-C (GC-C) agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Linaclotide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02417170 | CONSTELLA | 290 MCG | CAPSULE | ABBVIE CORPORATION | MARKETED |
| 02469510 | CONSTELLA | 72 MCG | CAPSULE | ABBVIE CORPORATION | MARKETED |